Betmiga prolonged-release tablets 25mg

Manufacturer
Avara Pharmaceutical Technologies, Inc.(UNITED STATES)

Registraction Number
MAL15015106ACRZ


Content:

• Active Ingredient: Betamethasone 25mg
• Excipients: Various inactive ingredients to stabilize the tablet

• Inflammatory Conditions: Used to reduce inflammation in conditions such as arthritis, allergies, and skin conditions.
• Autoimmune Disorders: Used to manage symptoms of autoimmune diseases like lupus and multiple sclerosis.
• Adrenal Insufficiency: Used as a replacement therapy in patients with adrenal insufficiency.

1. Dosage and Administration: The dosage and administration should be determined by a healthcare provider based on the specific medical condition and patient needs. It is typically taken once daily, with or without food.
2. Storage: Store at room temperature, away from moisture and heat.
3. Handling: Take the tablet with a full glass of water. Do not crush or chew the tablet.
4. Monitoring: Regular monitoring of blood pressure, blood sugar levels, and other relevant parameters as advised by the healthcare provider.